Follow on Google News News By Tag Industry News Country(s) Industry News
Follow on Google News | Duke University Hospital Selects Simplifi 797 for Quality Assurance Regarding Drug CompoundingWeb-based software helps hospital document compliance practices consistently
By: Pharmacy OneSource “At Duke University Hospital we struggled with meeting USP 797 documentation requirements in a consistent and standardized fashion across the enterprise,” Simplifi 797 is a web-based application that automates, integrates and streamlines the quality activities and documentation required to meet USP Chapter 797. Simplifi 797 manages task scheduling for environmental monitoring and automates the reporting of exceptions and compliance. DeCoske said Duke University Hospital found the included policies and competency checklists to be extremely useful for the many pharmacy areas that compound sterile medications. “The best part about Simplifi797 is the reporting,” DeCoske said. “We can print a simple report and trend how we are performing with documentation on a monthly basis and pinpoint our areas for improvement.” More information about Simplifi 797 can be found at: www.simplifi797.com About Pharmacy OneSource (www.pharmacyonesource.com) Pharmacy OneSource is healthcare's #1 Software-as- About Duke University Hospital (www.dukemedicine.org) Duke University Hospital is a 943-bed tertiary and quaternary care hospital that is consistently rated as one of the top hospitals in the United States. It offers comprehensive diagnostic and therapeutic facilities, including a regional emergency/trauma center; a major surgery suite containing 31 operating rooms, one of 40 National Cancer Institute designated comprehensive cancer centers, an Eye Center, the Duke Heart Center and the Children's Health Center. The facility also functions as a research hospital with a federally funded general clinical research unit where medical advances are achieved and applied, and as a teaching hospital for students of medicine, nursing, and the allied health sciences. End
Account Email Address Disclaimer Report Abuse
|
|